Cargando…

A comprehensive analysis of clinical, quality of life, and cost-effectiveness outcomes of key treatment options for benign prostatic hyperplasia

Treatment options for men with moderate-to-severe lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH) have variable efficacy, safety, and retreatment profiles, contributing to variations in patient quality of life and healthcare costs. This study examined the long-term cost...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chughtai, Bilal, Rojanasarot, Sirikan, Neeser, Kurt, Gultyaev, Dmitry, Fu, Shuai, Bhattacharyya, Samir K., El-Arabi, Ahmad M., Cutone, Ben J., McVary, Kevin T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9012364/ https://www.ncbi.nlm.nih.gov/pubmed/35427376 http://dx.doi.org/10.1371/journal.pone.0266824

Ejemplares similares

Cost-Effectiveness and Budget Impact of Emerging Minimally Invasive Surgical Treatments for Benign Prostatic Hyperplasia
por: Chughtai, Bilal, et al.
Publicado: (2021)

Water vapor thermal therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: Systematic review and meta-analysis
por: Miller, Larry E., et al.
Publicado: (2020)

Long-Term Risk of Surgery Following First Diagnosis of Benign Prostatic Hyperplasia in Middle-Aged Men
por: Rojanasarot, Sirikan, et al.
Publicado: (2022)

Patients' Perspectives on Attributes While Choosing Minimally Invasive Surgery for Benign Prostatic Hyperplasia Procedures: Experience from Men Undergoing Water Vapor Thermal Therapy
por: Rojanasarot, Sirikan, et al.
Publicado: (2023)

Putting Patients Ahead by Leaving Nothing Behind: An Emerging Treatment Paradigm in Minimally Invasive Surgical Therapy for Benign Prostatic Hyperplasia
por: McVary, Kevin T, et al.
Publicado: (2021)

Preservation of Sexual Function 5 Years After Water Vapor Thermal Therapy for Benign Prostatic Hyperplasia
por: McVary, Kevin T., et al.
Publicado: (2021)

Water vapor thermal therapy to alleviate catheter-dependent urinary retention secondary to benign prostatic hyperplasia
por: McVary, Kevin T., et al.
Publicado: (2019)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Commentary on “Solving the benign prostatic hyperplasia puzzle”
por: Thomas, Dominique, et al.
Publicado: (2018)

Treatment satisfaction among men with concurrent benign prostatic hyperplasia and erectile dysfunction treated with tadalafil or other phosphodiesterase type-5 inhibitor combinations
por: Lee, Lulu K, et al.
Publicado: (2016)

The Impact of Early Involvement in a Postdischarge Support Program for Ostomy Surgery Patients on Preventable Healthcare Utilization
por: Rojanasarot, Sirikan
Publicado: (2018)

Poor clinical guideline adherence and inappropriate testing for incident lower urinary tract symptoms associated with benign prostatic hyperplasia
por: Welliver, Charles, et al.
Publicado: (2022)

Recent advances in managing benign prostatic hyperplasia: The Rezūm System
por: Guelce, Dominique, et al.
Publicado: (2018)

The use of a single daily dose of tadalafil to treat signs and symptoms of benign prostatic hyperplasia and erectile dysfunction
por: Gacci, Mauro, et al.
Publicado: (2013)

Contemporary review of the 532 nm laser for treatment of benign prostatic hyperplasia
por: Chughtai, Bilal, et al.
Publicado: (2015)

Assessment of Frailty and Association With Progression of Benign Prostatic Hyperplasia Symptoms and Serious Adverse Events Among Men Using Drug Therapy
por: Bauer, Scott R., et al.
Publicado: (2021)

Therapeutic options in the treatment of benign prostatic hyperplasia
por: Sandhu, Jaspreet S
Publicado: (2009)

The role of photovaporization of the prostate in small volume benign prostatic hyperplasia and review of the literature
por: Thomas, Dominique, et al.
Publicado: (2019)

Does urodynamics predict voiding after benign prostatic hyperplasia surgery in patients with detrusor underactivity?
por: Thomas, Dominique, et al.
Publicado: (2019)

Various treatment options for benign prostatic hyperplasia: A current update
por: Shrivastava, Alankar, et al.
Publicado: (2012)

Quantifying the number of US men with erectile dysfunction who are potential candidates for penile prosthesis implantation
por: Rojanasarot, Sirikan, et al.
Publicado: (2023)

Benign Cutaneous Cysts: A Comprehensive Analysis of 1160 cases
por: Chughtai, Anila, et al.
Publicado: (2023)

Procedural Intervention for Benign Prostatic Hyperplasia in Men ≥ Age 70 Years – A Review of Published Literature
por: Codelia-Anjum, Alia J, et al.
Publicado: (2023)

Preface on current topics in men’s health
por: Welliver, Charles, et al.
Publicado: (2016)

Technique considerations and complication management in transurethral resection of the prostate and photoselective vaporization of the prostate
por: Welliver, Charles, et al.
Publicado: (2017)

A systematic review of discounting in national health economic evaluation guidelines: healthcare value implications
por: Williams, Abimbola O, et al.
Publicado: (2022)

Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis
por: Shin, Young Eun, et al.
Publicado: (2023)

Ejaculations and Benign Prostatic Hyperplasia: An Impossible Compromise? A Comprehensive Review
por: Couteau, Nicolas, et al.
Publicado: (2021)

Cost-effectiveness analysis of camrelizumab in the second-line treatment for advanced or metastatic esophageal squamous cell carcinoma in China
por: Yang, Fan, et al.
Publicado: (2021)

Benign Prostatic Hyperplasia
Publicado: (2015)

Benign prostatic hyperplasia and new treatment options – a critical appraisal of the UroLift system
por: McNicholas, Thomas Anthony
Publicado: (2016)

Integrative multiplatform molecular profiling of benign prostatic hyperplasia identifies distinct subtypes
por: Liu, Deli, et al.
Publicado: (2020)

Ejaculatory dysfunction in the treatment of lower urinary tract symptoms
por: DeLay, Kenneth Jackson, et al.
Publicado: (2016)

Benign prostatic hyperplasia as a progressive disease: a guide to the risk factors and options for medical management
por: Emberton, M, et al.
Publicado: (2008)

Medical therapy options for aging men with benign prostatic hyperplasia: focus on alfuzosin 10 mg once daily
por: Roehrborn, Claus G, et al.
Publicado: (2008)

Management options for the treatment of benign prostatic hyperplasia with or without erectile dysfunction: a focus on tadalafil and patient considerations
por: Alsaikhan, Bader, et al.
Publicado: (2014)

Bipolar Transurethral Enucleation of the Prostate: Is it a size-independent endoscopic treatment option for symptomatic benign prostatic hyperplasia?
por: Bebi, Carolina, et al.
Publicado: (2021)

Nitric Oxide Synthase is Necessary for Normal Urogenital Development
por: Bond, Christopher, et al.
Publicado: (2013)

OP6 Measuring and Quantifying Lost Productivity Due to Priority Diseases: A Review of the Past 10 Years and Reflections on the Unprecedented Changes and Implications Emerging with COVID-19
por: Rojanasarot, S, et al.
Publicado: (2022)

Silodosin in the treatment of benign prostatic hyperplasia
por: Rossi, Maxime, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_di5f1lhhdgvdi2h0qe9glthbfk